Valuation: Dr. Reddy's Laboratories Limited

Capitalization 1,088B 11.54B 9.81B 8.98B 8.48B 15.74B 15.93B 106B 41.47B 522B 43.3B 42.4B 1,806B P/E ratio 2026 *
21.3x
P/E ratio 2027 * 23.3x
Enterprise value 1,059B 11.24B 9.55B 8.74B 8.26B 15.33B 15.51B 104B 40.38B 509B 42.16B 41.28B 1,758B EV / Sales 2026 *
3.09x
EV / Sales 2027 * 2.89x
Free-Float
70.34%
Yield 2026 *
0.61%
Yield 2027 * 0.59%
1 day-1.04%
1 week-2.24%
Current month-2.24%
1 month+8.10%
3 months+4.20%
6 months+7.30%
Current year+1.75%
1 week 1,269
Extreme 1269
1,328.2
1 month 1,188.35
Extreme 1188.35
1,376
Current year 1,149
Extreme 1149
1,376
1 year 1,130.05
Extreme 1130.05
1,377.95
3 years 876.68
Extreme 876.68
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - -
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5d. change 1-year change 3-years change Capi.($)
-1.04%-2.24%+11.48%+30.98% 11.54B
-2.48%-0.98%+26.94%+120.44% 869B
-0.57%-2.57%+42.20%+36.37% 536B
-1.02%-2.73%+8.29%+36.30% 359B
-0.43%-0.60%+18.90%+11.56% 327B
+0.30%-1.17%+31.77%+12.09% 281B
+0.05%-0.42%+24.42%+20.97% 278B
-0.33%-0.05%+44.37%-5.30% 277B
-1.76%+4.42%-32.32%-49.34% 206B
-0.04%-0.17%+21.02%+40.33% 178B
Average -0.73%-0.45%+19.71%+25.44% 332.2B
Weighted average by Cap. -1.00%+0.24%+24.20%+43.97%

Financials

2026 *2027 *
Net sales 343B 3.64B 3.09B 2.83B 2.68B 4.97B 5.03B 33.59B 13.09B 165B 13.66B 13.38B 570B 358B 3.8B 3.23B 2.96B 2.79B 5.18B 5.24B 35.04B 13.65B 172B 14.25B 13.96B 594B
Net income 50.87B 540M 459M 420M 396M 736M 745M 4.98B 1.94B 24.42B 2.02B 1.98B 84.43B 46.64B 495M 420M 385M 364M 675M 683M 4.56B 1.78B 22.39B 1.86B 1.82B 77.42B
Net Debt -28.78B -305M -259M -238M -224M -416M -421M -2.82B -1.1B -13.82B -1.15B -1.12B -47.77B -54.22B -575M -489M -448M -423M -785M -794M -5.3B -2.07B -26.03B -2.16B -2.11B -90B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,811
Date Price Change Volume
08/05/26 1,293.25 -1.04% 35,545
07/05/26 1,306.80 -0.28% 38,933
06/05/26 1,310.50 +3.11% 94,111
05/05/26 1,270.95 -1.32% 59,875
04/05/26 1,287.95 -2.65% 201,745
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
38
Last Close Price
1,293.25INR
Average target price
1,327.14INR
Spread / Average Target
+2.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 500124 Stock